Since the moment that Coartem Dispersible was launched in 2009, 100 million treatments for children suffering from malaria have been delivered to 39 malaria-endemic countries. This child-friendly therapy was developed thanks to a public-private partnership between the Medicines for Malaria Venture (MMV) and Novartis. The MMV Foundation, which receives support from the SDC, is also a part of the Swiss Malaria Group.
- Delivery of child-friendly antimalarial hits the 100 million mark
Medicines for Malaria Venture, press release
Download (PDF, 138 KB) : [en]
Contributing to the global fight against malaria
|Despite continued progress in malaria control, malaria is still a major burden of disease in many countries, particularly in sub-Saharan Africa. When combating the health and economic effects of malaria in its partner countries, SDC stresses not only prevention but also access to medicines.|
In sub-Saharan countries alone, 765 million people are at risk of contracting malaria every year.
|Although malaria is decreasing in all regions, 225 million people suffer from malaria infections every year.|
|Approximately 800,000 people die annually due to malaria, 90% of the deaths occur in sub-Saharan Africa.|
|Most at risk are young children and pregnant women.|
Many countries have made impressive progress in controlling malaria, resulting in reduced child mortality and a decreased number of malaria cases. These results have been made possible through
improved coordination of the different global actors, massive investments in malaria control and the availability of efficient tools for prevention, diagnosis and treatment. However, growing
resistance to anti-malarial drugs and insecticides pose a huge challenge to sustaining these achievements.
The SDC focus: together against malaria
SDC contributes to the fight against malaria through bilateral as well as multilateral cooperation. In partner countries that are highly malaria endemic, SDC backs specific projects that tackle malaria by increasing mosquito-net coverage, strengthening health systems and supporting community-based initiatives. At international level, SDC contributes to the fight against malaria with financial contributions to global initiatives such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and to internationally recognised academic institutions as well as public private partnerships that are driving innovative research and the development of new prevention means, drugs and diagnostic tools.
Raise awareness and sensitise
Additional Information and DocumentsDocuments
- SDC Factsheet Multilateral organisations: GFATM
Switzerland and the Global Fund to fight AIDS, Tuberculosis and Malaria GFATM
Download (PDF, 1092 KB) : [de] [en] [fr]
- Malaria Factsheet
Download (PDF, 305 KB) : [de] [fr]
- Communiqué du « Swiss Malaria Group » a l'occasion de la Journée Mondiale contre le Paludisme, 25.0
Download (PDF, 122 KB) : [de] [fr]
- Improving access to essential malaria treatments with "SMS" in Tanzania
Download (PDF, 192 KB) : [en]
- Swiss Malaria Group
The aim of the Swiss Malaria Group is to raise awareness of malaria and its impacts among decision m...
- MDG 6: Combat HIV/AIDS, malaria and other diseases
Articles and Press releases
- Federal Councillor Didier Burkhalter receives Global Fund executive director Mark Dybul
- World Malaria Day 2013: Winning entries in online photo contest bring importance of prevention into sharp relief
- 25 April, World Malaria Day: An exhibition, a competition and unremitting commitment
- The fight against malaria: Accolade for SDC partner institute in Tanzania